Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra

Mitochondrial damage is implicated in highly active antiretroviral therapy (HAART) toxicity. HIV infection also causes mitochondrial toxicity (MT). Differentiating between the two is critical for HIV management. Our objective was to test the utility of the Mitochondrial Disease Criteria (MDC) and th...

Full description

Saved in:
Bibliographic Details
Main Authors: Allison Langs-Barlow, Lorna Renner, Karol Katz, Veronika Northrup, Elijah Paintsil
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2013/249171
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467920452681728
author Allison Langs-Barlow
Lorna Renner
Karol Katz
Veronika Northrup
Elijah Paintsil
author_facet Allison Langs-Barlow
Lorna Renner
Karol Katz
Veronika Northrup
Elijah Paintsil
author_sort Allison Langs-Barlow
collection DOAJ
description Mitochondrial damage is implicated in highly active antiretroviral therapy (HAART) toxicity. HIV infection also causes mitochondrial toxicity (MT). Differentiating between the two is critical for HIV management. Our objective was to test the utility of the Mitochondrial Disease Criteria (MDC) and the Enquête Périnatale Française (EPF) to screen for possible HAART related MT in HIV-infected children in Ghana. The EPF and MDC are compilations of clinical symptoms, or criteria, of MT: a (+) score indicates possible MT. We applied these criteria retrospectively to 403 charts of HIV-infected children. Of those studied, 331/403 received HAART. Comparing HAART exposed and HAART naïve children, the difference in EPF score, but not MDC, approached significance (). Young age at HIV diagnosis or at HAART initiation was associated with (+) EPF (). Adherence to HAART trended toward an association with (+) EPF (). Exposure to nevirapine, abacavir, or didanosine increased risk of (+) EPF (OR = 3.55 (CI = 1.99–6.33), 4.76 (2.39–9.43), 4.93 (1.29–18.87)). Neither EPF nor MDC identified a significant difference between HAART exposed or naïve children regarding possible MT. However, as indicators of HAART exposure are associated with (+) EPF, it may be a candidate for prospective study of possible HAART related MT in resource-poor settings.
format Article
id doaj-art-e0e65a53789143f5be746d2332ea4013
institution Kabale University
issn 2090-1240
2090-1259
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series AIDS Research and Treatment
spelling doaj-art-e0e65a53789143f5be746d2332ea40132025-08-20T03:25:59ZengWileyAIDS Research and Treatment2090-12402090-12592013-01-01201310.1155/2013/249171249171Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in AccraAllison Langs-Barlow0Lorna Renner1Karol Katz2Veronika Northrup3Elijah Paintsil4Department of Pediatrics, Yale School of Medicine, New Haven, CT 06520, USADepartment of Child Health, Korle Bu Teaching Hospital, University of Ghana Medical School, P.O. Box kb77, Accra, GhanaYale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT 06520, USAYale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT 06520, USADepartment of Pediatrics, Yale School of Medicine, New Haven, CT 06520, USAMitochondrial damage is implicated in highly active antiretroviral therapy (HAART) toxicity. HIV infection also causes mitochondrial toxicity (MT). Differentiating between the two is critical for HIV management. Our objective was to test the utility of the Mitochondrial Disease Criteria (MDC) and the Enquête Périnatale Française (EPF) to screen for possible HAART related MT in HIV-infected children in Ghana. The EPF and MDC are compilations of clinical symptoms, or criteria, of MT: a (+) score indicates possible MT. We applied these criteria retrospectively to 403 charts of HIV-infected children. Of those studied, 331/403 received HAART. Comparing HAART exposed and HAART naïve children, the difference in EPF score, but not MDC, approached significance (). Young age at HIV diagnosis or at HAART initiation was associated with (+) EPF (). Adherence to HAART trended toward an association with (+) EPF (). Exposure to nevirapine, abacavir, or didanosine increased risk of (+) EPF (OR = 3.55 (CI = 1.99–6.33), 4.76 (2.39–9.43), 4.93 (1.29–18.87)). Neither EPF nor MDC identified a significant difference between HAART exposed or naïve children regarding possible MT. However, as indicators of HAART exposure are associated with (+) EPF, it may be a candidate for prospective study of possible HAART related MT in resource-poor settings.http://dx.doi.org/10.1155/2013/249171
spellingShingle Allison Langs-Barlow
Lorna Renner
Karol Katz
Veronika Northrup
Elijah Paintsil
Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
AIDS Research and Treatment
title Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
title_full Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
title_fullStr Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
title_full_unstemmed Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
title_short Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
title_sort performance of clinical criteria for screening of possible antiretroviral related mitochondrial toxicity in hiv infected children in accra
url http://dx.doi.org/10.1155/2013/249171
work_keys_str_mv AT allisonlangsbarlow performanceofclinicalcriteriaforscreeningofpossibleantiretroviralrelatedmitochondrialtoxicityinhivinfectedchildreninaccra
AT lornarenner performanceofclinicalcriteriaforscreeningofpossibleantiretroviralrelatedmitochondrialtoxicityinhivinfectedchildreninaccra
AT karolkatz performanceofclinicalcriteriaforscreeningofpossibleantiretroviralrelatedmitochondrialtoxicityinhivinfectedchildreninaccra
AT veronikanorthrup performanceofclinicalcriteriaforscreeningofpossibleantiretroviralrelatedmitochondrialtoxicityinhivinfectedchildreninaccra
AT elijahpaintsil performanceofclinicalcriteriaforscreeningofpossibleantiretroviralrelatedmitochondrialtoxicityinhivinfectedchildreninaccra